Healthcare & Life Sciences
We help healthcare and life sciences organizations turn patient, clinical and operational data into better outcomes — from resource planning to compliance reporting — without disrupting the systems clinicians already rely on.
How we can help
- Clinical and operational reporting built for the people who use it
- Capacity, staffing and resource planning
- Quality and regulatory reporting, designed around how patient data has to be handled
- Claims and revenue-cycle analytics
Where we work
- Providers
- Payers
- Pharma & biotech
- Medical devices
Providers
Hospitals and provider groups rarely lack data. It is spread across an EHR, a scheduling system, a billing platform, a theatre management tool and a long tail of departmental spreadsheets, and no two of them agree on what an encounter is. The work is almost never about collecting more; it is about reconciling what already exists into a number a department head is willing to act on. That reconciliation is unglamorous and it is where most of the value sits, because until it is done every dashboard built on top inherits the disagreement underneath. Clinical staff are also the least forgiving audience for a reporting tool: if it is slow, or it contradicts what they saw on the ward this morning, they stop opening it and never come back. So we build for the people reading it rather than the people commissioning it, and we prove the numbers against a source they already trust before asking anyone to rely on them.
Our capabilities
- Service-line dashboards covering volumes, length of stay and throughput
- Bed, theatre and clinic capacity models used for rostering
- Readmission and outcome reporting by cohort and by clinician
- Revenue-cycle views tying coding and denials back to their source
- Quality submissions assembled from existing systems rather than re-keyed
Work we have delivered
- Replaced a manually assembled quarterly quality submission with a monitored pipeline
- Built a theatre utilisation model the rostering team plans against
- Reconciled admission, encounter and discharge definitions across EHR, scheduling and billing
- Stood up service-line dashboards refreshed before the morning huddle
Payers
Payer analytics lives or dies on claims data that arrives late, incomplete, and in several formats at once from submitters who each interpret the standard slightly differently. Most of the value is in making that pipeline dependable before anyone builds a model on top of it, because a forecast resting on a feed that silently drops a submitter for a week is worse than no forecast. The second requirement is explainability: any number that reaches a regulator, a board or a provider negotiation has to be traceable back to the claims that produced it, months after the person who ran it has moved on. That pushes the design toward reproducible, versioned pipelines rather than clever one-off analysis. Once those two things hold, the analytical questions — cost trend, network performance, risk — become tractable in a way they simply are not beforehand.
Our capabilities
- Claims ingestion and normalisation across formats and submitters
- Medical loss ratio and cost-trend reporting by plan and population
- Provider network performance and utilisation analysis
- Fraud, waste and abuse detection on claim patterns
- Member risk stratification for care-management programs
Work we have delivered
- Rebuilt a claims feed that silently drops submitters into one with delivery alerting
- Traced a published MLR figure end to end, from claim line to board pack
- Delivered provider network utilisation reporting for contract renegotiation
- Deployed claim-pattern anomaly detection into the existing investigations workflow
Pharma & biotech
Research, trial and commercial data rarely sit together, yet the questions worth asking cross all three: what the trial actually showed, how the product is performing in market, and whether both can be evidenced to someone who was not there. The binding constraint is traceability. Every figure has to be explainable long after the analysis ran, which rules out the spreadsheet lineage most organisations are quietly relying on. Trial data arrives from multiple sites and vendors on different schedules and in different shapes, so consolidation is a standing task rather than a one-off migration. Manufacturing and quality data adds a third rhythm again. The work is therefore as much about building a defensible pipeline and keeping its history as it is about the analysis at the end of it, and we plan for audit from the first design decision rather than retrofitting it.
Our capabilities
- Clinical trial data consolidation across sites and vendors
- Manufacturing and batch-quality analytics
- Commercial performance reporting by territory and channel
- Pharmacovigilance signal monitoring
- Audit-ready lineage showing how each figure was produced
Work we have delivered
- Consolidated trial data arriving from multiple sites and vendors into one analysis-ready store
- Built an audit-ready lineage layer over an existing regulatory submission
- Automated commercial performance reporting currently rebuilt each cycle by hand
- Set up batch-quality monitoring with alerting on out-of-trend results
Medical devices
Connected devices generate far more telemetry than most organisations manage to use, and the questions that actually matter need that telemetry joined to records living somewhere else entirely. Whether a unit is about to fail is a maintenance question; whether it is being used as intended is a clinical and commercial one; whether a pattern of complaints is a real signal is a regulatory one. None can be answered from the device feed alone. So the first task is landing telemetry reliably at production volume, and the second is joining it to service history, warranty and account data that were never designed to be read together. Only then does predictive maintenance become something more than a demonstration. Post-market surveillance sits on the same foundation, which is why it is worth building once and properly.
Our capabilities
- Device telemetry pipelines at production volume
- Predictive maintenance and failure-pattern models
- Field service and warranty analytics
- Post-market surveillance and complaint trend reporting
- Utilisation reporting by account and by device
Work we have delivered
- Held a telemetry feed steady through a tenfold volume increase without gaps
- Built a predictive maintenance model on consolidated failure history
- Joined device, service history and account into one record for post-market surveillance
- Settled a billing dispute by reconciling usage the two sides counted differently